LaunchWorks Manufacturing Lab is Now LaunchWorks CDMO
The news comes after the company received its FDA registered ISO 13485 as a CDMO.
LaunchWorks Manufacturing Lab, a life sciences company, announced on June 8, 2020 that it is now LaunchWorks CDMO (contract development and manufacturing organization).
The news comes after the company received its FDA registered ISO 13485 as a CDMO, a press release said. Integron Global, a packaging solutions provider, acquired Launchworks in 2017 and has since added additional service offerings, including an automation program. Most recently, the company has responded to the COVID-19 pandemic.
“The enhancement of our services is an important step in showcasing our commitment to deliver a comprehensive scope of capabilities, to support our clients’ path to commercialization. Our service offerings are designed to meet each customer’s unique set of challenges,” said Jeff Kelly, general manager of LaunchWorks CDMO, in the press release. “This is a crucial step as we expand our ability to support the world’s changing needs due to the pandemic as well as incorporate automation and device manufacturing. Launchworks, with our service suite ranging from package design to fulfillment and technologies, is uniquely positioned to meet the challenge of helping companies translate their science into commercial products, thereby contributing to the improvement in world health.”
Source: LaunchWorks CDMO
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Pharmaceutical Tariffs Are Imminent: How Industry is Bracing for Impact
April 16th 2025On April 14, 2025, the Trump Administration launched a national security-driven investigation into pharmaceuticals, a move that will likely result in tariffs being placed on pharmaceutical drugs, ingredients, and other components that are imported from outside of the United States.
